Bone fiber technology for veterinary markets
TheraCell-VET is the veterinary products division of TheraCell. The company is dedicated to bringing the advantages of TheraCell’s demineralized bone fiber technology and product pipeline to the veterinary market. Our flagship product VET Fiber Matrix™ is the only veterinary bone grafting product that offers osteoinductivity and osteoconductivity in a natural, additive free product.
Improving Bone Grafting Options
TheraCell was founded in 2008 to exploit technology developed at the Hebrew
University by leading researcher Dan Gazit PhD and his team. The technology
included a stem cell sorting device to concentrate MSC’s from adipose tissue
and Oxygenation technology to improve survival of stem cell solutions.
Guided by a team of influential spine surgeons, and led by experienced
Medical Device executives, TheraCell has further developed methodologies
and gained patent protection for applying the oxygenation technology to
demineralized bone matrix products. We have also developed a proprietary,
patent pending process for the production of demineralized bone fibers.
Our DBF™ technology has allowed the development of a number of
Fiber Matrix™ products. We also have a proprietary, patent pending
process to enhance the osteoinductivity of demineralized cancellous bone.